hemostat
function
felin
immunodefici
viru
fiv
seroposit
fiv
felin
leukemia
viru
felv
seroposit
cat
evalu
compar
refer
valu
clinic
healthi
cat
fivposit
cat
divid
group
group
includ
asymptomat
carrier
group
ii
compris
sick
fivinfect
cat
ill
like
influenc
hemostat
system
group
includ
fivposit
cat
diseas
potenti
associ
coagulopathi
platelet
count
fivfelvinfect
cat
significantli
lower
healthi
cat
p
wherea
differ
group
fivposit
cat
variabl
group
p
ii
p
p
os
thrombocytopenia
plateletslpl
present
fivposit
fivfelvposit
cat
platelet
aggreg
induc
collagen
pgml
adenosin
diphosph
adp
pmoll
thrombin
iuml
significantli
differ
healthi
cat
plasma
coagul
system
evalu
measur
onestag
prothrombin
time
ospt
activ
partial
thromboplastin
time
aptt
thrombin
time
fibrinogen
concentr
coagul
factor
assay
fibrinogen
fibrin
degrad
product
fdp
plasma
exchang
test
ospt
similar
fivseroposit
cat
healthi
control
group
cat
fiv
infect
howev
markedli
shorter
clot
time
healthi
cat
use
modifi
test
system
emostat
disord
occur
cours
differ
h
viral
infect
cat
dissemin
intravascular
coagul
dic
complic
felin
infecti
periton
viru
fipv
felin
panleucopenia
viru
infect
felin
leukemia
viru
felv
infect
caus
thrombocytopenia
seldom
discoveri
felin
immunodefici
viru
fiv
virolog
featur
pathogenesi
clinic
patholog
behavior
well
ec
r
b
e
report
hemostat
disord
associ
fiv
infect
rare
moder
thrombocytopenia
diseas
identifi
fivposit
purpos
studi
character
primari
secondari
hemostat
abnorm
fivinfect
cat
iuml
significantli
differ
healthi
cat
plasma
coagul
system
evalu
measur
onestag
prothrombin
time
ospt
activ
partial
thromboplastin
time
aptt
thrombin
time
fibrinogen
concentr
coagul
factor
assay
fibrinogen
fibrin
degrad
product
fdp
plasma
exchang
test
ospt
similar
fivseroposit
cat
healthi
control
group
cat
fiv
infect
howev
markedli
shorter
clot
time
healthi
cat
use
modifi
test
system
emostat
disord
occur
cours
differ
h
viral
infect
cat
dissemin
intravascular
coagul
dic
complic
felin
infecti
periton
viru
fipv
felin
panleucopenia
viru
infect
felin
leukemia
viru
felv
infect
caus
thrombocytopenia
seldom
thrombocythemia
discoveri
felin
immunodefici
viru
fiv
virolog
featur
pathogenesi
clinic
patholog
behavior
well
ec
r
b
e
report
hemostat
disord
associ
fiv
infect
rare
moder
thrombocytopenia
diseas
identifi
fivposit
purpos
studi
character
primari
secondari
hemostat
abnorm
fivinfect
cat
cat
consid
healthi
base
normal
physic
examin
hemogram
within
refer
rang
neg
enzym
link
immunosorb
assay
elisa
fiv
felv
healthi
cat
present
clinic
vaccin
neuter
blood
collect
jugular
cephal
vein
healthi
cat
fivposit
cat
cat
concurr
fiv
felv
infect
tabl
list
age
breed
gender
cat
evalu
small
aliquot
blood
ml
collect
tube
contain
edet
acid
edta
platelet
count
hemogram
remaind
sampl
ml
ad
tube
contain
sodium
citrat
bloodanticoagul
aggreg
studi
coagul
assay
p
group
fivinfect
cat
fivfelv
infect
aptt
measur
differ
commerci
avail
test
modifi
plasma
assay
markedli
prolong
compar
healthi
cat
aptti
modif
p
apttp
p
except
group
ill
cat
fiv
cat
fivfelv
infect
plasma
sampl
beyond
refer
rang
thrombin
time
also
significantli
prolong
cat
fiv
fivfelv
infect
p
ol
valu
fivposit
cat
refer
rang
mean
fibrinogen
concentr
cat
fiv
fivfelv
infect
higher
healthi
control
group
p
ool
factor
vlll
activ
cat
fiv
infect
time
higher
healthi
cat
factor
activ
cat
group
cat
prolong
aptt
factor
ix
xi
activ
rang
markedli
prolong
aptt
fivposit
cat
could
shorten
consider
plasma
exchang
test
use
felin
pool
plasma
alter
coagulogram
fivseroposit
cat
relat
clinic
stage
concurr
diseas
definit
explan
distinct
disord
within
intrins
plasma
coagul
system
fivinfect
cat
found
fiv
felv
serolog
perform
use
commerci
avail
elisa
test
cite
combo
idexx
laboratori
westbrook
cat
less
intens
color
develop
elisa
either
test
repeatedli
twice
interv
month
diagnosi
confirm
western
blot
fivand
felvseroposit
cat
clientown
patient
clinic
small
anim
thu
differ
stage
infect
tabl
fivposit
cat
divid
three
group
group
includ
asymptomat
cat
group
compris
fivseroposit
cat
ill
like
induc
hemostat
abnorm
eg
gingiv
diarrhea
skin
diseas
group
includ
fivinfect
cat
concurr
diseas
may
associ
coagulopathi
uremia
liver
diseas
neoplasia
etc
plateletrich
plasma
prp
platelet
aggreg
obtain
centrifug
citrat
blood
centrifug
beckman
gpkr
beckman
instrument
munich
minut
centrifug
minut
result
plateletpoor
plasma
ppp
prp
dilut
ppp
platelet
number
case
lower
platelet
count
undilut
prp
use
platelet
aggreg
test
aliquot
frozen
ppp
store
hart
nolt
incub
water
bath
minut
c
glass
tube
quantif
fibrinogen
fibrin
degrad
product
fdp
centrifug
minut
serum
store
test
capillari
tube
fill
edtaanticoagul
blood
place
thrombo
plu
sarstedt
numbrecht
germani
tube
minut
platelet
count
hemacytomet
within
hour
sampl
collect
platelet
aggreg
studi
perform
autom
platelet
aggreg
coagul
tracer
apact
labor
ahrensburg
germani
within
hour
venipunctur
prp
adjust
light
transmiss
ppp
transmiss
prp
pl
incub
second
aggreg
start
ad
pl
agonist
follow
agonist
use
collagen
pgml
kollagenreagen
horm
hormonchemi
munich
germani
adenosinediphosph
adp
pmoll
fimol
sigma
diagnost
st
loui
mo
thrombin
iuml
testthrombin
behringwerk
marburg
germani
one
germani
compar
standard
curv
pool
plasma
healthi
cat
serum
serial
dilut
glycin
buffer
tenmicrolit
aliquot
dilut
serum
latex
suspens
gentli
mix
test
card
evalu
agglutin
minut
later
highest
dilut
clear
agglutin
consid
agglutin
titer
citrat
plasma
ml
fivinfect
cat
highli
prolong
aptt
replac
ml
pool
plasma
healthi
cat
aptt
determin
sfatist
analysi
nonparametr
kruskalw
analysi
varianc
use
compar
platelet
count
coagulogram
screen
test
fibrinogen
group
rvseroposit
cat
felvfivinfect
cat
healthi
control
tabl
summar
result
coagulogram
platelet
count
clinic
healthi
fivand
fiv
felvinfect
cat
platelet
count
fivfelvposit
cat
lower
control
group
p
wherea
fivseroposit
cat
group
p
p
p
variabl
thrombocytopenia
without
evid
spontan
bleed
present
fivinfect
upper
respiratori
sign
neoplasia
dermat
fivfelvinfect
cat
liver
diseas
dermat
fever
platelet
aggreg
could
induc
healthi
fivposit
cat
agonist
mean
maxim
aggreg
aggreg
gradient
similar
fivinfect
cat
healthi
one
tabl
ospt
significantli
differ
healthi
fivposit
cat
test
evalu
ospti
modifi
osptl
differ
fivseroposit
cat
control
depend
dilut
dilut
group
p
p
p
dilut
group
p
p
p
aptt
significantli
prolong
group
fivinfect
cat
aptti
group
p
p
p
dilut
group
p
p
p
fivfelvseroposit
cat
aptti
p
dilut
p
tabl
apttl
valu
beyond
refer
rang
fivposit
cat
five
plasma
sampl
fivfelv
seroposit
cat
also
beyond
refer
rang
aptt
second
aptt
test
signific
differ
control
group
observ
group
p
p
fivfelvinfect
cat
p
tt
also
prolong
fiv
group
p
p
p
fivfelvposit
cat
p
compar
healthi
control
tabl
fibrinogen
concentr
elev
refer
rang
fivseroposit
fivfelvseroposit
cat
result
remark
differ
healthi
one
p
oo
tabl
seventeen
fivinfect
fivfelvinfect
cat
fibrinogen
concentr
mgdl
result
platelet
count
hemostasi
screen
test
vari
consider
among
group
fivinfect
cat
caus
underli
diseas
seem
influenc
hemostat
system
tabl
coagul
factor
assay
factor
viii
ix
xi
xii
perform
fivseroposit
cat
prolong
aptt
aptti
mean
sd
apttl
dilut
mean
sd
mean
sd
k
tt
mean
sd
factor
viii
activ
higher
fivinfect
cat
mean
factor
viii
activ
fivseroposit
cat
mean
factor
activ
fivposit
cat
factor
activ
factor
ix
xi
activ
fivposit
cat
rang
highest
agglutin
titer
fibrinogen
fibrin
degrad
product
fivposit
cat
prolong
aptt
refer
rang
plasma
exchang
test
perform
cat
prolong
aptt
result
clear
shorten
coagul
time
aptti
ad
felin
pool
plasma
addit
pool
plasma
led
success
normal
coagul
time
plasma
exchang
incub
hour
yield
similar
result
report
coagul
disord
cours
fiv
infect
cat
rare
probabl
hemorrhag
diathes
occur
infrequ
grindem
et
briefli
describ
bleed
disord
fivseroposit
cat
fivposit
cat
leukopenia
thrombocytopenia
associ
gastrointestin
bleed
describ
friend
et
publish
refer
rang
platelet
count
normal
cat
r
b
l
e
refer
rang
studi
healthi
cat
similar
report
howev
investig
report
rang
p
l
e
l
e
p
l
thrombocytopenia
play
import
role
variou
infecti
also
occur
cat
fiv
infect
studi
fivseroposit
cat
thrombocytopen
accord
shel
itiv
asymptomat
cat
itiv
cat
diseas
influenc
hemostat
system
itiv
cat
ill
potenti
associ
coagulopathi
reagenz
undilut
plasma
ton
et
preval
thrombocytopenia
fivposit
cat
mild
thrombocytopenia
plateletspl
found
investig
fivinfect
third
report
mention
one
thrombocytopen
cat
among
fivseroposit
one
cat
thrombocytopenia
associ
spontan
bleed
thrombocytopenia
appear
frequent
cat
concurr
fiv
felv
infect
probabl
fivfelvposit
cat
increas
risk
develop
myeloprolif
turn
result
thrombocytopenia
due
myelophthisi
studi
fivfelvseroposit
cat
thrombocytopen
addit
platelet
count
platelet
function
vital
primari
hemostasi
platelet
clinic
healthi
cat
aggreg
well
ad
collagen
adp
arachidon
acid
thrombin
respond
ristocetin
kaolin
ei
n
e
p
h
r
n
e
thrombocytopathi
occur
cours
variou
felin
diseas
liver
diseas
leukemia
chkdiakhigashi
yndrome
howev
studi
platelet
aggreg
fivseroposit
cat
differ
healthi
cat
ospt
evalu
extrins
common
pathway
plasma
coagul
system
result
studi
reveal
refer
rang
test
ospti
use
measur
ospt
clearli
differ
shown
plasma
dilut
lead
signific
prolong
ospt
earlier
studi
laboratori
plasma
dilut
dba
buffer
led
smoother
standard
curv
improv
readabl
assay
healthi
alter
extrins
pathway
coagul
system
fivposit
cat
detect
modifi
osptl
test
howev
unmodifi
ospti
test
yield
similar
result
fivinfect
healthi
cat
unfortun
definit
explan
discrep
possibl
diagnost
test
current
avail
cat
publish
refer
rang
aptt
vari
consider
use
test
system
differ
gentri
evalu
reagent
found
remark
differ
howev
author
regard
reagent
test
use
diagnosi
sever
coagul
reagent
evalu
studi
result
differ
refer
rang
second
aptt
second
use
plasma
dilut
recommend
evalu
aptt
improv
sensit
compar
undilut
plasma
healthi
cat
plasma
sampl
studi
need
dilut
ratio
aptti
vitro
alter
intrins
coagul
system
detect
fivinfect
cat
studi
character
prolong
aptt
similar
test
reagent
aptti
modifi
test
assay
aptt
sensit
howev
dilut
provid
addit
benefit
evalu
aptt
tt
evalu
gener
fibrin
fibrinogen
addit
thrombin
influenc
heparin
fdp
sever
dysfibrinogenemia
refer
rang
tt
vari
consider
depend
thrombin
concentr
use
refer
rang
similar
publish
literth
fibrinogen
concentr
quantifi
use
method
c
l
yield
refer
rang
mgml
refer
rang
similar
publish
author
mgdl
hyperfibrinogenemia
previous
report
fivand
fivfelvseroposit
cat
yet
common
cat
inflammatori
ie
e
clauss
method
detect
function
clottabl
fibrinogen
unlik
dysfibrinogenemia
account
prolong
tt
isol
prolong
aptt
may
caus
clot
factor
defici
intrins
pathway
defici
factor
viii
ix
xi
report
hemophilia
factor
viii
defici
associ
mark
prolong
aptt
howev
studi
f
viii
activ
elev
fivposit
cat
evalu
like
reflect
fact
f
viii
acut
phase
reactant
plasma
activ
increas
cours
inflammatori
proces
factor
ix
defici
hemophilia
b
also
associ
prolong
aptt
cat
particularli
mark
prolong
screen
test
occur
combin
factor
ix
defici
factor
ixact
fivseroposit
cat
evalu
within
refer
rang
caus
abnorm
hemostat
system
previou
report
suggest
f
defici
rel
common
healthi
howev
f
activ
therefor
f
activ
fivposit
cat
studi
like
explain
prolong
aptt
circul
fdp
appear
common
cat
high
concentr
circul
fdp
pg
dl
may
caus
prolong
aptt
human
unlik
concentr
fdp
fivinfect
cat
studi
consequ
dic
moreov
concentr
probabl
high
enough
effect
plasma
exchang
test
perform
fivseroposit
cat
markedli
prolong
aptt
elucid
coagul
disord
human
circul
inhibitor
coagul
occur
variou
diseas
progress
inhibitori
antibodi
exert
effect
hour
plasma
incub
distinguish
direct
inhibit
agent
immedi
inhibit
singl
coagul
factor
eg
f
viii
ix
caus
prolong
aptt
ospt
antibodi
usual
immunoglobulin
g
igm
interfer
phospholipid
involv
coagul
process
howev
despit
prolong
clot
time
spontan
bleed
occur
concurr
thrombocytopenia
factor
defici
one
report
coagul
disord
induc
circul
inhibitor
f
xi
mix
normal
pool
plasma
patient
plasma
without
incub
hour
result
slow
normal
aptt
gradual
increas
f
xi
activ
result
author
conclud
inhibitori
immunoglobulin
may
preent
studi
result
plasma
exchang
test
reveal
alreadi
mixtur
patient
felin
pool
plasma
correct
prolong
aptt
therefor
presenc
inhibit
antibodi
rel
unlik
base
report
literatur
result
satisfi
explan
abnorm
intrins
pathway
plasma
coagul
system
fivinfect
cat
